Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Passiflora vs mefenamic acid for primary dysmenorrhea
IRCT20230406057831N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of passiflora incarnata and Mefenamic acid in primary dysmenorrhea (PD) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started May 2023; status: completed.
02
Drugs
passiflora incarnataMefenamic acid
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on IRCT20230406057831N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230406057831N1.